Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.

Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

E4 and E7 proteins with cervical cancer.

Genetic stability of a recombinant adenovirus vaccine vector seed library expressing human papillomavirus type 16 E6 and E7 proteins.

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.

Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera.

Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58.

Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif.

Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16.

Detection of human antibody against the human papillomavirus type 16 E7 protein.

Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.

Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein.

Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage.

Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames.

Ethyl 1,8-naphthyridone-3-carboxylates downregulate human papillomavirus-16 E6 and E7 oncogene expression.

Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis: type-specific reaction of anti-HPV 16 antibodies.

Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation.

Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6.

E7 mRNA test in cervical cytological samples.

E7 oncogene expression as cervical disease biomarker.

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.

Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes.

E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.

Suggest Documents

Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

E4 and E7 proteins with cervical cancer.

Genetic stability of a recombinant adenovirus vaccine vector seed library expressing human papillomavirus type 16 E6 and E7 proteins.

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.

Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera.

Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58.

Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif.

Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16.

Detection of human antibody against the human papillomavirus type 16 E7 protein.

Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.

Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein.

Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage.

Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames.

Ethyl 1,8-naphthyridone-3-carboxylates downregulate human papillomavirus-16 E6 and E7 oncogene expression.

Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis: type-specific reaction of anti-HPV 16 antibodies.

Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation.

Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6.

E7 mRNA test in cervical cytological samples.

E7 oncogene expression as cervical disease biomarker.

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.

Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes.

E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.

Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.

Recommend Documents

Follow Us